BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11206095)

  • 1. [Nonsurgical therapy methods in hepatocellular carcinoma].
    Wettstein M; Häussinger D
    Praxis (Bern 1994); 2001 Jan; 90(1-2):15-20. PubMed ID: 11206095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatocellular carcinoma: percutaneous ethanol injection/transarterial chemoembolization/radiofrequency thermoablation].
    Allgaier HP; Rossi S; Deibert P; Zuber I; Hering M; Blum HE
    Praxis (Bern 1994); 2000 Jun; 89(24):1056-60. PubMed ID: 10902462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic interventional radiology procedures in hepatocellular carcinoma].
    Huppert PE; Viebahn R; Duda SH; Lauchart W
    Zentralbl Chir; 1994; 119(11):787-93. PubMed ID: 7531377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of hepatocellular carcinoma].
    Allgaier HP; Deibert P; Blum U; Spangenberg HC; Moser E; Blum HE
    Schweiz Med Wochenschr; 1996 Nov; 126(46):1984-94. PubMed ID: 8984607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current therapeutic strategies for hepatocellular carcinoma, 2].
    Wallner I; Hartmann H; Ramadori G
    Leber Magen Darm; 1994 Sep; 24(5):187-201. PubMed ID: 7968178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsurgical treatment of hepatocellular carcinoma.
    Llovet JM; Sala M; Bruix J
    Liver Transpl; 2000 Nov; 6(6 Suppl 2):S11-5. PubMed ID: 11084079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate.
    Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H
    Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
    Vallone P; Catalano O; Izzo F; Siani A
    Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hepatocellular carcinoma.
    Yu AS; Keeffe EB
    Rev Gastroenterol Disord; 2003; 3(1):8-24. PubMed ID: 12684589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.
    Helmberger T; Dogan S; Straub G; Schrader A; Jüngst C; Reiser M; Waggershauser T; Jakobs T; Hoffmann RT; Löhe F; Graeb C; Rau HG; Schauer R; Jauch KW; Caselmann WH; Göke B; Jüngst D
    Digestion; 2007; 75(2-3):104-12. PubMed ID: 17598962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoembolization and bland embolization: a critical appraisal.
    Befeler AS
    Clin Liver Dis; 2005 May; 9(2):287-300, vii. PubMed ID: 15831274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma: multimodality management.
    Christians KK; Pitt HA; Rilling WS; Franco J; Quiroz FA; Adams MB; Wallace JR; Quebbeman EJ
    Surgery; 2001 Oct; 130(4):554-9; discussion 559-60. PubMed ID: 11602884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hepatocellular carcinoma: medical options.
    Fried MW
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S92-7. PubMed ID: 9742500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.
    Yamakado K; Nakatsuka A; Akeboshi M; Shiraki K; Nakano T; Takeda K
    Oncol Rep; 2004 Jan; 11(1):105-9. PubMed ID: 14654911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary liver and bile duct tumors: approach to conservative therapy].
    Henne-Bruns D; Marks HG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():343-7. PubMed ID: 9931637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival.
    Bharat A; Brown DB; Crippin JS; Gould JE; Lowell JA; Shenoy S; Desai NM; Chapman WC
    J Am Coll Surg; 2006 Oct; 203(4):411-20. PubMed ID: 17000383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for the management of hepatocellular carcinoma.
    Schwartz M; Roayaie S; Konstadoulakis M
    Nat Clin Pract Oncol; 2007 Jul; 4(7):424-32. PubMed ID: 17597707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nonsurgical therapy of hepatocellular carcinoma].
    Allgaier HP; Galandi D; Olschewski M; Blum HE
    Praxis (Bern 1994); 2002 Aug; 91(35):1387-92. PubMed ID: 12233280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.